Overview
Alberto Martini is an Assistant Professor and the Director of Research in the Department of Urology.
He is extensively trained in robotic and laparoscopic surgery, having been mentored by pioneers in minimally invasive surgery. His professional experience spans the USA (New York City and Houston), Europe (Florence, Milan, Dresden, Prague, and Toulouse), and Australia (Melbourne). He also received specialized training in gene therapy for bladder cancer under Dr. Dinney, a gene therapy pioneer for bladder cancer, at MD Anderson Cancer Center.
Dr. Martini is passionate about advancing research and utilizing innovative statistical methods to enhance healthcare approaches and patient outcomes. He has authored over 170 research articles and earned national and international recognition for his work. Notably, he holds a patent for the integration of 3D models during robotic prostatectomy, reflecting his commitment to improving surgical precision and patient care.
His clinical and research focus is on urological oncology, specifically prostate, bladder, and kidney cancer.
Dr. Martini actively contributes to several international working groups, including the European Association of Urology (EAU) – Young Academic Urologists group on Prostate Cancer. He is also an associate member of the scientific working group of the Robotic Urology Section of the EAU and the EAU Guidelines on muscle-invasive and metastatic bladder cancer.
Dr. Martini is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), Upper Tract Urothelial Carcinoma (UTUC), Prostatectomy, and Nephrectomy.
His clinical research consists of co-authoring 454 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 29 articles in the study of Renal Cell Carcinoma (RCC).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- EPO
- HMO
- PPO
- MEDICARE MAPD
- OTHER MEDICARE
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
222 Piedmont Ave, Cincinnati, OH 45219
Additional Areas of Focus
Dr. Martini has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Dayton Physicians LLC
Erik Weise is an Urologist in Centerville, Ohio. Dr. Weise is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Congenital Mesoblastic Nephroma, WT1-Related Wilms Tumor Syndromes, Wilms Tumor, Reconstructive Urology Surgery, and Nephrectomy. Dr. Weise is currently accepting new patients.
Oxford Physical Therapy And Rehabilitation
Daniel Robertshaw is an Urologist in Mason, Ohio. Dr. Robertshaw is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Muscle Invasive Bladder Cancer, Congenital Mesoblastic Nephroma, Familial Prostate Cancer, Ureteroscopy, and Reconstructive Urology Surgery. Dr. Robertshaw is currently accepting new patients.
James Donovan is an Urologist in Cincinnati, Ohio. Dr. Donovan is rated as an Advanced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, Renal Cell Carcinoma (RCC), Ureteroscopy, and Reconstructive Urology Surgery.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Bladder ReconstructionDr. Martini isDistinguished. Learn about Bladder Reconstruction.
- NephrectomyDr. Martini isDistinguished. Learn about Nephrectomy.
- Prostate CancerDr. Martini isDistinguished. Learn about Prostate Cancer.
- ProstatectomyDr. Martini isDistinguished. Learn about Prostatectomy.
- Renal Cell Carcinoma (RCC)Dr. Martini isDistinguished. Learn about Renal Cell Carcinoma (RCC).
- Advanced
- Muscle Invasive Bladder CancerDr. Martini isAdvanced. Learn about Muscle Invasive Bladder Cancer.
- Non-Muscle Invasive Bladder CancerDr. Martini isAdvanced. Learn about Non-Muscle Invasive Bladder Cancer.
- Upper Tract Urothelial Carcinoma (UTUC)
- Experienced
- Adult Soft Tissue SarcomaDr. Martini isExperienced. Learn about Adult Soft Tissue Sarcoma.
- BoilsDr. Martini isExperienced. Learn about Boils.
- CarbuncleDr. Martini isExperienced. Learn about Carbuncle.
- FolliculitisDr. Martini isExperienced. Learn about Folliculitis.
- LymphadenectomyDr. Martini isExperienced. Learn about Lymphadenectomy.
- Solitary Fibrous TumorDr. Martini isExperienced. Learn about Solitary Fibrous Tumor.